The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective study

• Автори: Chun-Chi Yang (Автор), Ya-Wen Tsai (Автор), Su-Hung Wang (Автор), Jheng-Yan Wu (Автор), Ting-Hui Liu (Автор), Wan-Hsuan Hsu (Автор), Po-Yu Huang (Автор), Min-Hsiang Chuang (Автор), Ming-Jen Sheu (Автор), Chih-Cheng Lai (Автор)
• Формат: Книга
• Опубліковано: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

Background: The effectiveness of the novel oral antiviral agents, nirmatrelvir plus ritonavir and molnupiravir, in treating COVID-19 in patients with nonalcoholic fatty liver disease is unclear.Objective: To assess the effectiveness of novel oral antiviral agents against COVID-19 among patients with...